Immunomodulatory Activities of Chitin Microparticles on Leishmania major-infected Murine Macrophages

Archives of Medical Research

Volumn 42, Issue 7, 2011, Pages 572-576

  Dehghani, Fatemeh ^a   Haji Molla Hoseini, Mostafa ^a   Memarnejadian, Arash ^b   Yeganeh, Farshid ^a   Rezaie, Alireza Mokarram ^c   Khaze, Vahid ^b   Sattari, Mandana ^a   Darbandi Tamijani, Hassan ^a   Labibi, Farzaneh ^a   Mossaffa, Nariman ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Chitin; Leishmania major; Macrophages; Nitric oxide; TNF

Indexed keywords

CHITIN; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL THERAPY; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOMODULATION; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHITIN; CYTOKINES; FEMALE; LEISHMANIA MAJOR; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855512719     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.11.005     Document Type: Article

References (24)

1. Muzzarelli R.A. Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers. Mar Drugs 2010, 8:292-312.
2. Nishimura K., Nishimura S., Nishi N., et al. Immunological activity of chitin and its derivatives. Vaccine 1984, 2:93-99.
3. Shibata Y., Foster L.A., Metzger W.J., et al. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun 1997, 65:1734-1741.
4. Shibata Y., Metzger W.J., Myrvik Q.N. Chitin particle-induced cell mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J Immunol 1997, 159:2462-2467.
5. Da Silva C.A., Hartl D., Liu W., et al. TLR-2 and IL-17A in chitin induced macrophage activation and acute inflammation. J Immunol 2008, 181:4279-4286.
6. Reese T.A., Liang H.E., Tager A.M., et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007, 447:92-96.
7. Zhu Z., Zheng T., Homer R.J., et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004, 304:1678-1682.
8. Ozdemir C., Yazi D., Aydogan M., et al. Treatment with chitin microparticles is protective against lung histopathology in a murine asthma model. Clin Exp Allergy 2006, 36:960-968.
9. Hamajima K., Kojima Y., Matsui K., et al. Chitin micro-particles (CMP): a useful adjuvant for inducing viral specific immunity when delivered intranasally with an HIV-DNA vaccine. Viral Immunol 2003, 16:541-547.
10. Shibata Y., Honda I., Justice J.P., et al. Th1 adjuvant N-acetyl-D-glucosamine polymer upregulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10- knockout and wild-type mice. Infect Immun 2001, 69:6123-6130.
11. Shibata Y., Foster L.A., Bradfield J.F., et al. Oral administration of chitin downregulates serum IgE levels and lung eosinophilia in the allergic mouse. J Immunol 2000, 164:1314-1321.
12. Nishiyama A., Tsuji S., Yamashita M., et al. Phagocytosis of N-acetyl-D-glucosamine particles, a Th1 adjuvant, by RAW264.7 cells results in MAPK activation and TNF-α, but not IL-10, production. Cell Immunol 2006, 239:103-112.
13. Strong P., Clark H., Reid K. Intranasal application of chitin microparticles downregulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy. Clin Exp Allergy 2002, 32:1794-1800.
14. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
15. Nahrevanian H., Farahmand M., Aghighi Z., et al. Pharmacological evaluation of anti-leishmanial activity by invivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis. Exp Parasitol 2007, 116:233-240.
16. Barroso P.A., Marco J.D., Calvopina M., et al. A trial of immunotherapy against Leishmania amazonensis infection invitro and invivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate. J Antimicrob Chemother 2007, 59:1123-1129.
17. El-On J., Bazarsky E., Sneir R. Leishmania major: Invitro and invivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod. Exp Parasitol 2007, 116:156-162.
18. Valderinez M., Lonardoni C., Russo M., et al. Essential role of platelet-activating factor in control of Leishmania amazonensis infection. Infect Immun 2000, 68:6355-6661.
19. Ferreira A.S., de Souza M.A., Barbosa N.R., et al. Leishmania amazonensis: xylitol as inhibitor of macrophage infection and stimulator of macrophage nitric oxide production. Exp Parasitol 2008, 119:74-79.
20. Aranaz I., Mengíbar M., Harris R., et al. Functional characterization of chitin and chitosan. Curr Chem Biol 2009, 3:203-230.
21. Nahrevanian H. Involvement of nitric oxide and its up/down stream molecules in the immunity against parasitic infections. Braz J Infect Dis 2009, 13:440-448.
22. Muniz-Junqueira M., de Paula-Coelho V.N. Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-α production, but only via TNF-α it indirectly increases nitric oxide production by phagocytes of healthy individuals, invitro. Int Immunopharmacol 2008, 8:1633-1638.
23. Lee Ch, Da Silva C.A., Dela Cruz Ch, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011, 73:479-501.
24. Da Silva C.A., Chalouni C., Williams A., et al. Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J Immunol 2009, 182:3573-3582.